Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter pharmacokinetic study of HD od PD patients receiving
erythropoietin. Patients were administered 100mg of iron sucrose undiluted by slow IV push
over 5 minutes. Patients underwent serial blood draws and were subsequently followed for 7
days for safety endpoints.